||EPS - Basic
||Market Cap (m)
Angle Share Discussion Threads
Showing 44951 to 44975 of 44975 messages
|On the website 2, but seems to be ctDNA
|Lung cancer blood test, just been on BBC news|
|There is a big fire at the Christie Cancer Research Centre, just the sort of black swan event that can badly hit any research project.|
|Willfy - the video seems to be referring to CTDNA not CTC's|
|Worth having a look at on twitter, from cancer research ukBlood tests that analyse tumour DNA are showing promise for monitoring how cancer patients respond to treatment #DNADay17End of the video says liquid biopsy , so may well be Parsortix|
|Looking like some decent volume building now. Hoping this is the start of a re-rate before the results.|
|That 65p level just so happens to be around the old 64.5p placing. Once that goes...|
|Cant be long now until this realises its true potential.|
|But don't take too long, the trial results could be out tomorrow :)
|Crack on son, fill your boots.|
|Taking a position here early next week. The story is good and technically there's a very impressive divergence that is apparent both on the daily and weekly chart. It's viewable on both rsi and macd. Together with a massive volume week (biggest for almost 2 years) it's ripe for a decent bounce. Since topping in May 2015 it's not actually approached overbought on a number of indicators which in itself is quite remarkable.
That last low was engineered imo to snare a few stops - it's the lowest the share price has been since May 2013. The bounce out of that was very strong - the sp's taking a bit of a breather but I doubt it'll hang around for too long. 65p is the biggie. A close above that and I suspect this could regain 1.00 quite quickly.
The catalyst for much of the above will very likely be the impending news but I could see some buying in advance so as usual keep an eye on the volume.
|There seem to be quite a few references to Parsortix at moleculardxeurope.com which was on 10-13 April 2017 in Lisbon. I thought some of these may have come up on Twitter.|
|We live in hope, Semper.|
|Can't be far off test results release.
Also, those who were tested could be further assisted by follow-on tests?|
|Might even have a blue finish. Have a good holiday weekend all.|
|Good idea wells, but having read the BBC article, it seems a relatively small unit if they are only putting forward six people per day. I hope that they have plans to increase the scale.
Perhaps cost constraints would mean that the drug costs resulting from more rapid diagnosis of a higher volume of patients would put a dampener on it.
Easter shutdown has started!|
|A one stop shop for cancer diagnosis is being set up in cynon valley south wales.
An opportunity for Angle?|
|ANGLE plc (AIM: AGL OTCQX: ANPCY), the specialist medtech company with pioneering products for cancer diagnostics, is pleased to announce the appointment of Daniel Costin Danila, MD, as a Scientific Advisor to the Company with immediate effect.Dr Danila is a leader in the development and adoption of CTCs as predictive biomarkers to help clinicians select appropriate treatments.|
|I presume you know that he has been a scientific advisor to Angle since 2015.|
|Auphilman - I may be wrong,just that he seems to be a common denominator.|
|ah yes got him now.. well interesting point SV.. there is clearly work in the background we r never told.. take the Athens announcement..|
I dont recognise any of the names or institutions SV, but then there is no info i have found of how they intend to structure the research.|
|Anyone know if collaboration between Weill Cornell and Kettering Sloane on liquid biopsy has anything to do with AGL please?|
No volume at the mo. I wondered if we'd see a pick up as some buy in in preparation for the results. Still plenty of time I guess.|